德诺苏马布与腹腔大动脉化在透析患者中加速进展有关
Tetsuya Seto1,2,3, Kiminori Yukata2, Zenzo Fujii4
1Department of Orthopedic Surgery, St. Hill Hospital, Yamaguchi, Japan.
概括
德诺苏马布改善了透析患者的骨矿物质密度,但也加速了血管化. 这表明,在使用德诺苏马布治疗慢性病患者的骨健康时,仔细监测心血管影响至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
背景情况:
- 慢性病 (CKD) 破坏骨和矿物代谢,增加骨质疏松症和血管化的风险,主要的死亡因素.
- 众所周知,RANKL抑制剂丹诺苏马布可以增加骨矿物密度 (BMD),但其对血管化的影响仍在争论中.
研究的目的:
- 调查德诺苏马布对透析患者血管化和骨硬化的影响.
- 为了比较接受德诺苏马布和对照组的透析患者在两年内化和骨质量变化的变化.
主要方法:
- 25名透析患者接受德诺苏马布治疗的回顾性研究,与21名对照组对比.
- 每年进行骨质量评估和计算机断层扫描 (CT) 扫描,以检测腹腔大动脉血管化体积和阿加斯顿分数.
主要成果:
- 德诺苏马布显著增加腰椎骨质量 (8.5%对1.5%,p=0.0079).
- 德诺苏马布组的血管化体积显著增加 (32.8%对19.3%,p=0.0476) 和阿加斯顿得分 (34.6%对20.5%,p=0.0483).
结论:
- 代诺苏马布对透析患者的骨健康有益.
- 在透析患者中使用德诺苏马布与血管化加速有关,需要仔细监测心血管.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
127
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
127
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
35
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
35
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Antihypertensive Drugs: Action of Calcium Channel Blockers
784
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
784
Hormones and Bone Tissue
3.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K


